Corvus Pharmaceuticals, Inc.
Pembelian

My CRVS Price Targets

437
Hello all,

As you all may have noticed from doing your research that there has been a quantifiable spike in insider buying by the President and Director of Orbimed Advisors.

On February 17th, 2021 there was an Initial Public Offering at 3.50/share.

I have not made any extensive due diligence on the company yet, solely interested in the high amount of shares bought up by insiders.

Thank you

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.